These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 20074411

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Hepatotoxicity in patients co-infected with tuberculosis and HIV-1 while receiving non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy and rifampicin-containing anti-tuberculosis regimen.
    Mankhatitham W, Lueangniyomkul A, Manosuthi W.
    Southeast Asian J Trop Med Public Health; 2011 May; 42(3):651-8. PubMed ID: 21706943
    [Abstract] [Full Text] [Related]

  • 3. Outcomes of nevirapine- and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapy.
    Boulle A, Van Cutsem G, Cohen K, Hilderbrand K, Mathee S, Abrahams M, Goemaere E, Coetzee D, Maartens G.
    JAMA; 2008 Aug 06; 300(5):530-9. PubMed ID: 18677025
    [Abstract] [Full Text] [Related]

  • 4. Concomitant use of nonnucleoside analogue reverse transcriptase inhibitors and rifampicin in TB/HIV type 1-coinfected patients.
    Sathia L, Obiorah I, Taylor G, Kon O, O'Donoghue M, Gibbins S, Walsh J, Winston A.
    AIDS Res Hum Retroviruses; 2008 Jul 06; 24(7):897-901. PubMed ID: 18671475
    [Abstract] [Full Text] [Related]

  • 5. A randomized trial comparing plasma drug concentrations and efficacies between 2 nonnucleoside reverse-transcriptase inhibitor-based regimens in HIV-infected patients receiving rifampicin: the N2R Study.
    Manosuthi W, Sungkanuparph S, Tantanathip P, Lueangniyomkul A, Mankatitham W, Prasithsirskul W, Burapatarawong S, Thongyen S, Likanonsakul S, Thawornwa U, Prommool V, Ruxrungtham K, N2R Study Team.
    Clin Infect Dis; 2009 Jun 15; 48(12):1752-9. PubMed ID: 19438397
    [Abstract] [Full Text] [Related]

  • 6. Nevirapine versus efavirenz for patients co-infected with HIV and tuberculosis: a systematic review and meta-analysis.
    Jiang HY, Zhang MN, Chen HJ, Yang Y, Deng M, Ruan B.
    Int J Infect Dis; 2014 Aug 15; 25():130-5. PubMed ID: 24911886
    [Abstract] [Full Text] [Related]

  • 7. Nevirapine-based antiretroviral therapy started early in the course of tuberculosis treatment in adult Malawians.
    van Oosterhout JJ, Kumwenda JJ, Beadsworth M, Mateyu G, Longwe T, Burger DM, Zijlstra EE.
    Antivir Ther; 2007 Aug 15; 12(4):515-21. PubMed ID: 17668560
    [Abstract] [Full Text] [Related]

  • 8. Standard-dose efavirenz vs. standard-dose nevirapine in antiretroviral regimens among HIV-1 and tuberculosis co-infected patients who received rifampicin.
    Manosuthi W, Mankatitham W, Lueangniyomkul A, Chimsuntorn S, Sungkanuparph S.
    HIV Med; 2008 May 15; 9(5):294-9. PubMed ID: 18400076
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evaluation of a pro-active strategy for managing tuberculosis-HIV co-infection in a UK tertiary care setting.
    Wake RM, Poulikakos P, Groth J, Harrison TS, Macallan DC.
    Int J STD AIDS; 2013 Apr 15; 24(4):263-8. PubMed ID: 23635810
    [Abstract] [Full Text] [Related]

  • 14. Long-term follow-up of nevirapine-treated patients in a single-centre cohort.
    Colafigli M, Di Giambenedetto S, Bracciale L, Fanti I, Prosperi M, Cauda R, De Luca A.
    HIV Med; 2009 Sep 15; 10(8):461-9. PubMed ID: 19459991
    [Abstract] [Full Text] [Related]

  • 15. Outcomes of HIV-infected children with tuberculosis who are started on antiretroviral therapy in Malawi.
    Bong CN, Chen SC, Jong YJ, Tok TS, Hsu CF, Schouten EJ, Makombe SD, Yu JK, Harries AD.
    Int J Tuberc Lung Dis; 2007 May 15; 11(5):534-8. PubMed ID: 17439677
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Nevirapine levels after discontinuation of rifampicin therapy and 60-week efficacy of nevirapine-based antiretroviral therapy in HIV-infected patients with tuberculosis.
    Manosuthi W, Ruxrungtham K, Likanonsakul S, Prasithsirikul W, Inthong Y, Phoorisri T, Sungkanuparph S.
    Clin Infect Dis; 2007 Jan 01; 44(1):141-4. PubMed ID: 17143831
    [Abstract] [Full Text] [Related]

  • 18. Acceptance of anti-retroviral therapy among patients infected with HIV and tuberculosis in rural Malawi is low and associated with cost of transport.
    Zachariah R, Harries AD, Manzi M, Gomani P, Teck R, Phillips M, Firmenich P.
    PLoS One; 2006 Dec 27; 1(1):e121. PubMed ID: 17205125
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.